NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
0.4690
-0.0024 (-0.51%)
At close: Jul 14, 2026, 4:00 PM EDT
0.4641
-0.0049 (-1.04%)
Pre-market: Jul 15, 2026, 6:01 AM EDT
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $4.28 million as of July 15, 2026. Its market cap has decreased by -76.69% in one year.
Market Cap
4.28M
Enterprise Value
8.36M
1-Year Change
-76.69%
Ranking
Category
Stock Price
$0.47
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $4.28M, a decrease of -78.14%. That is a compound annual growth rate of -28.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 4.28M | -67.34% |
| Dec 31, 2025 | 13.11M | -60.90% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
| Dec 22, 2021 | 19.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nephros | 38.54M |
| Milestone Scientific | 35.50M |
| Harvard Bioscience | 26.75M |
| Retractable Technologies | 20.66M |
| Jin Medical International | 15.34M |
| Bionano Genomics | 13.20M |
| Regentis Biomaterials | 13.16M |
| Cuprina Holdings (Cayman) Limited | 10.97M |